Eaton Vance Management
SBIO icon

Eaton Vance Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Eaton Vance Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25
Closed -$1K – 2579
2021
Q2 		$1K Buy
+25
New +$1.2K ﹤0.01% 2773

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Eaton Vance Management's SBIO Position: Q3 2021 in Review

Eaton Vance Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2021, closing a stake of 25 shares — an estimated $1K sold.

Eaton Vance Management first reported a position in SBIO in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 60 funds tracked by Wall St. Rank hold SBIO as of Q3 2021.

  • Eaton Vance Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2021 after selling out during the quarter.
  • Eaton Vance Management sold 25 ALPS Medical Breakthroughs ETF shares in Q3 2021, an estimated $1K.
  • Eaton Vance Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2021 and held it in 1 quarter.
  • Eaton Vance Management's ALPS Medical Breakthroughs ETF position peaked at $1K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2021.

Based on Eaton Vance Management's 13F filing for Q3 2021, filed 15 Nov 2021.